Contract facts
FederalNo full NAICS 325414 intel page yet. Browse NAICS intelligence
PURCHASE OF 1,500 OCTAPLASLG UNITS FOR THE UNITED STATES MARINE CORP is a federal award for Defense Health Agency held by Octapharma Usa Inc. Estimated value $1.8M ($1.8M obligated). Current period of performance ends Jul 3, 2026. Place of performance: FREDERICK MD.
PURCHASE OF 1,500 OCTAPLASLG UNITS FOR THE UNITED STATES MARINE CORP
Recompete timing
PublicCurrent PoP ended Jul 3, 2026 (49 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordOctapharma Usa Inc — $9.2M obligated across 8 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942726FE025?
HT942726FE025 (Purchase of 1 500 octaplaslg UNITS) is a Defense Health Agency award with a potential value of $1.8M, currently held by Octapharma Usa Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HT942726FE025?
Defense Health Agency awarded HT942726FE025 to Octapharma Usa Inc (potential $1.8M).
Who is the incumbent on HT942726FE025?
Octapharma Usa Inc is the incumbent with $9.2M across 8 related awards in SCOUT’s public footprint. The current period of performance ends Jul 3, 2026.
When does Octapharma Usa Inc’s HT942726FE025 come up for recompete?
SCOUT tracks a period-of-performance end of Jul 3, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.